Ya I definitely think it is a great deal, was just curious as to how it lined up with Mono-therapy according to others. I definitely like the 50% royalties and most of the burden on the partner. Makes it so Cytodyn just sits back and collects money. And helps us as shareholders because we see more income.
So just a quick question, the payment to the company that sold Leronlimab to Cytodyn, would that be part of the upfront 50mil for launch and refresh my memory, what was the amount? 20 mil or something like that?